EvidentMedsEvidentMeds
DirectoryEvidenceInteractionsSupport

Can you take Mounjaro® / Zepbound® with Ozempic® / Wegovy® / Rybelsus®?

Evidence-based interaction check between Mounjaro® / Zepbound® and Ozempic® / Wegovy® / Rybelsus®

MajorEditorially reviewed · last updated April 15, 2025

High risk — avoid this combination unless there is no good alternative.

Severe nausea, vomiting, diarrhea, dehydration, and a higher risk of hypoglycemia in patients also on insulin or a sulfonylurea. Pancreatitis risk also rises.

Why this happens (mechanism)

Both semaglutide (Ozempic) and tirzepatide (Mounjaro) act on the GLP-1 receptor (tirzepatide adds a GIP agonist effect). The two are functionally redundant — combining them doesn't improve A1C or weight loss but does multiply GI side effects, hypoglycemia (especially with insulin/sulfonylurea), and pancreatitis risk.

What to monitor

  • GI tolerance — persistent vomiting or inability to keep fluids down
  • Severe abdominal pain radiating to the back (pancreatitis flag)
  • Blood glucose, especially if also on insulin or a sulfonylurea
  • Weight, hydration status

Dose adjustment

Do not combine. Choose one GLP-1 receptor agonist; if switching between them, stop the first before starting the second (the two are not designed to be layered).

Safer alternatives to consider

Single GLP-1 agonist titrated to target

Either drug alone delivers the bulk of the achievable A1C and weight benefit.

Add metformin (if not already on it)

Different mechanism, no GLP-1 overlap, very low hypoglycemia risk.

Add an SGLT2 inhibitor (Jardiance)

Different mechanism — adds A1C lowering, weight loss, and cardiovascular/renal benefit without GLP-1 overlap.

Always discuss alternatives with your prescriber before making any change. The right choice depends on your other medications, conditions, and what is working for you today.

Evidence and sources

Check another pair

2 interactions found

Moderate

Delayed gastric emptying may reduce pill absorption, use barrier backup for 4 weeks at each dose escalation

Moderate

Absorption timing shifted 1–3 hours; take time-sensitive oral medications at a fixed time relative to tirzepatide injection

View Mounjaro® / Zepbound® View Ozempic® / Wegovy® / Rybelsus®

What this means

This summary is based on published interaction data from FDA prescribing information and clinical literature. It does not account for individual health factors, dosages, or other medications you may be taking. Always consult a qualified healthcare provider before making changes to your medication regimen.

Frequently Asked Questions

Is it safe to take Mounjaro® / Zepbound® with Ozempic® / Wegovy® / Rybelsus®?

High risk — avoid this combination unless there is no good alternative. Severe nausea, vomiting, diarrhea, dehydration, and a higher risk of hypoglycemia in patients also on insulin or a sulfonylurea. Pancreatitis risk also rises. Always discuss your full medication list with your prescriber.

What happens if you take Mounjaro® / Zepbound® and Ozempic® / Wegovy® / Rybelsus® together?

Both semaglutide (Ozempic) and tirzepatide (Mounjaro) act on the GLP-1 receptor (tirzepatide adds a GIP agonist effect). The two are functionally redundant — combining them doesn't improve A1C or weight loss but does multiply GI side effects, hypoglycemia (especially with insulin/sulfonylurea), and pancreatitis risk.

What should I monitor if I take both?

GI tolerance — persistent vomiting or inability to keep fluids down. Severe abdominal pain radiating to the back (pancreatitis flag). Blood glucose, especially if also on insulin or a sulfonylurea. Weight, hydration status.